Bluebird bio Inc ( (BLUE) ) has released its Q3 earnings. Here is a breakdown of the information Bluebird bio Inc presented to its investors.
William Blair analyst Sami Corwin reiterated a Hold rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares closed today at $0.36. Corwin covers the Healthcare sector, focusing on ...
WASHINGTON (Reuters) -Jeff Bezos' rocket company Blue Origin has signed a multi-launch deal with satellite communication ...
Since the Mideast wars began with Hamas’ initial Oct. 7, 2023, attack on Israel, many international airlines have halted, ...